Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Source filing unavailable
Q4 2016 · —
Revenue$5.33B$5.33B+2.8% vs Q4 2015 Net Income$798.00M$798.00M+4.0% vs Q4 2015 EPS Diluted$0.53$0.53+3.9% vs Q4 2015 Gross Profit$2,900,000,000+2.1% Operating Incomederived$789,000,000−3.2% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,170,000,000+41.3% Free Cash Flowderived$851,000,000+46.7% Margins · derivedGross margin54.4%−0.3 pt vs Q4 2015
Operating margin14.8%−0.9 pt vs Q4 2015
Net margin15.0%+0.2 pt vs Q4 2015